Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.

Article Details

Citation

Winum JY, Dogne JM, Casini A, de Leval X, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT

Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.

J Med Chem. 2005 Mar 24;48(6):2121-5.

PubMed ID
15771455 [ View in PubMed
]
Abstract

Targeting proteins overexpressed in hypoxic tumors is as an important means of controlling cancer disease. One such protein is the carbonic anhydrase (CA) isoenzyme IX, which in some types of tumors is overexpressed 150-200-fold. We report here a series of sulfonamide derivatives, prepared from 2-carbohydrazido- and 4-carbohydrazido-benzenesulfonamides, which were further derivatized by reaction with aryl isocyanates or arylsulfonyl isocyanates. Several low nanomolar CA IX inhibitors were detected in this way. SAR is discussed for the diverse types of inhibitors and their affinity for different isozymes, with the aim of obtaining isozyme-specific CA IX inhibitors, with putative applications as antitumor drugs.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
AcetazolamideCarbonic anhydrase 1Ki (nM)2507.520Details
AcetazolamideCarbonic anhydrase 2Ki (nM)127.520Details
BrinzolamideCarbonic anhydrase 2Ki (nM)37.520Details
DiclofenamideCarbonic anhydrase 1Ki (nM)12007.520Details
DiclofenamideCarbonic anhydrase 2Ki (nM)387.520Details
DorzolamideCarbonic anhydrase 1Ki (nM)500007.520Details
DorzolamideCarbonic anhydrase 2Ki (nM)97.520Details
EthoxzolamideCarbonic anhydrase 1Ki (nM)257.520Details
EthoxzolamideCarbonic anhydrase 2Ki (nM)87.520Details
MethazolamideCarbonic anhydrase 1Ki (nM)507.520Details
MethazolamideCarbonic anhydrase 2Ki (nM)147.520Details